CSPC 2021 has ended
avatar for Dr. Michael Hoffman

Dr. Michael Hoffman

University Health Network/University of Toronto
Senior Scientist, Princess Margaret Cancer Centre/Associate Professor, Departments of Medical Biophysics and Computer Sc
Toronto, ON
Dr. Michael Hoffman is a principal investigator at Princess Margaret Cancer Centre and Associate Professor in the Departments of Medical Biophysics and Computer ScienceUniversity of Toronto. He was named a CIHR New Investigator and has received several awards for his academic work, including the NIH K99/R00 Pathway to Independence Award, and the Ontario Early Researcher Award. Dr. Hoffman creates predictive computational models to understand interactions between genome, epigenome, and phenotype in human cancers. He implemented the genome annotation method Segway, which simplifies interpretation of large multivariate genomic datasets, and was a linchpin of the NIH ENCODE Project analysis. He is a lead of the University Health Network (UHN) Indicators for Research Impact and Organizational Excellence Working Group and a consultant member of the UHN DORA Advisory Group.

Social Handles
  • Twitter: @michaelhoffman